Identification of transthyretin variants by sequential proteomic and genomic analysis

Clinical Chemistry

Volumn 50, Issue 9, 2004, Pages 1544-1552

  Bergen III, H Robert ^a   Zeldenrust, Steven R ^b   Butz, Malinda L ^b   Snow, Denise S ^b   Dyck, Peter J ^b   Dyck, P James B ^b   Klein, Christopher J ^b   O'Brien, John F ^b   Thibodeau, Stephen N ^a,b   Muddiman, David C ^a,c  

^a MAYO CLINIC   (United States)

^b Mayo Clinic   (United States)

^c MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PREALBUMIN;

ANTIBODY AFFINITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; ELECTROSPRAY MASS SPECTROMETRY; FAMILIAL AMYLOIDOSIS; GENOME ANALYSIS; HUMAN; HUMAN CELL; POLYNEUROPATHY; PROTEIN POLYMORPHISM; PROTEIN VARIANT; PROTEOMICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AMYLOIDOSIS, FAMILIAL; DNA; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GENOMICS; GENOTYPE; HUMANS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PREALBUMIN; PROTEOMICS; SEQUENCE ANALYSIS, DNA; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 4344654840     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2004.033266     Document Type: Article

References (31)

1. Benson M. Amyloidosis. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited disease, 7th ed. New York: McGraw-Hill, 1995:4159-91. [The 8th ed. (2000) is also available.]
2. Ando Y, Tashima K, Tanaka Y, Nakazato M, Ericzon BG, Duraj FF, et al. Treatment of a Japanese patient with familial amyloidotic polyneuropathy with orthotopic liver transplantation. Intern Med 1994;33:730-2.
3. Bergethon PR, Sabin TD, Lewis D, Simms RW, Cohen AS, Skinner M. Improvement in the polyneuropathy associated with familial amyloid polyneuropathy after liver transplantation. Neurology 1996;47:944-51.
4. Suhr OB, Holmgren G, Steen L, Wikstrom L, Norden G, Friman S, et al. Liver transplantation in familial amyloidotic polyneuropathy. Follow-up of the first 20 Swedish patients. Transplantation 1995; 60:933-8.
5. Klabunde T, Petrassi HM, Oza VB, Raman P, Kelly JW, Sacchettini JC. Rational design of potent human transthyretin amyloid disease inhibitors. Nat Struct Biol 2000;7:312-21.
6. Lachmann HJ, Booth DR, Booth SE, Bybee A, Gilbertson JA, Gillmore JD, et al. Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis. N Engl J Med 2002;346:1786-91.
7. Yamashita T, Ando Y, Bernt Suhr O, Nakamura M, Sakashita N, Ohlsson PI, et al. A new diagnostic procedure to detect unknown transthyretin (TTR) mutations in familial amyloidotic polyneuropathy (FAP). J Neurol Sci 2000;173:154-9.
8. Nelis E, Warner LE, Vriendt ED, Chance PF, Lupski JR, Van Broeckhoven C. Comparison of single-strand conformation polymorphism and heteroduplex analysis for detection of mutations in Charcot-Marie-Tooth type 1 disease and related peripheral neuropathies. Eur J Hum Genet 1996;4:329-33.
9. Connors LH, Ericsson T, Skare J, Jones LA, Lewis WD, Skinner M. A simple screening test for variant transthyretins associated with familial transthyretin amyloidosis using isoelectric focusing. Biochim Biophys Acta 1998;1407:185-92.
10. Altland K, Winter P, Sauerborn MK. Electrically neutral microheterogeneity of human plasma transthyretin (prealbumin) detected by isoelectric focusing in urea gradients. Electrophoresis 1999; 20:1349-64.
11. Lim A, Prokaeva T, McComb ME, O'Connor PB, Theberge R, Connors LH, et al. Characterization of transthyretin variants in familial transthyretin amyloidosis by mass spectrometric peptide mapping and DNA sequence analysis. Anal Chem 2002;74:741-51.
12. Theberge R, Connors LH, Skinner M, Costello CE. Detection of transthyretin variants using immunoprecipitation and matrix-assisted laser desorption/ionization bioreactive probes: a clinical application of mass spectrometry. J Am Soc Mass Spectrom 2000;11:172-5.
13. Nakanishi T, Okamoto N, Tanaka K, Shimizu A. Laser desorption time-of-flight mass spectrometric analysis of transferrin precipitated with antiserum: a unique simple method to identify molecular weight variants. Biol Mass Spectrom 1994;23:230-3.
14. Wada Y, Matsuo T, Katakuse I, Suzuki T, Azuma T, Tsujino S, et al. Mass spectrometric detection of the plasma prealbumin (transthyretin) variant associated with familial amyloidotic polyneuropathy. Biochim Biophys Acta 1986;873:316-9.
15. Ando Y, Ohlsson PI, Suhr O, Nyhlin N, Yamashita T, Holmgren G, et al. A new simple and rapid screening method for variant transthyretin-related amyloidosis. Biochem Biophys Res Commun 1996;228:480-3.
16. Ranlov I, Ando Y, Ohlsson PI, Holmgren G, Ranlov PJ, Suhr OB. Rapid screening for amyloid-related variant forms of transthyretin is possible by electrospray ionization mass spectrometry. Eur J Clin Invest 1997;27:956-9.
17. Kishikawa M, Nakanishi T, Miyazaki A, Shimizu A, Nakazato M, Kangawa K, et al. Simple detection of abnormal serum transthyretin from patients with familial amyloidotic polyneuropathy by high-performance liquid chromatography/electrospray ionization mass spectrometry using material precipitated with specific antiserum. J Mass Spectrom 1996;31:112-4.
18. Tachibana N, Tokuda T, Yoshida K, Taketomi T, Nakazato M, Li YF, et al. Usefulness of MALDI/TOF mass spectrometry of immuno-precipitated serum variant transthyretin in the diagnosis of familial amyloid polyneuropathy. Amyloid 1999;6:282-8.
19. Bergen HR 3rd, Zeldenrust SR, Naylor S. An on-line assay for clinical detection of amyloidogenic transthyretin variants directly from serum. Amyloid 2003;10:190-7.
20. Shimizu A, Nakanishi T, Kishikawa M, Miyazaki A. Detection and identification of protein variants and adducts in blood and tissues: an application of soft ionization mass spectrometry to clinical diagnosis. J Chromatogr B Anal Technol Biomed Life Sci 2002; 776:15-30.
21. Ando Y, Almeida M, Ohlsson PI, Ando E, Negi A, Suhr O, et al. Unusual self-association properties of transthyretin Y114C related to familial amyloidotic polyneuropathy: effects on detection and quantification. Biochem Biophys Res Commun 1999;261: 264-9.
22. Nepomuceno AI, Mason CJ, Muddiman DC, Bergen HR 3rd, Zeldenrust SR. Detection of genetic variants of transthyretin by liquid chromatography-dual electrospray ionization Fourier-transform ion-cyclotron-resonance mass spectrometry. Clin Chem 2004;50:1535-43.
23. Getz EB, Xiao M, Chakrabarty T, Cooke R, Selvin PR. A comparison between the sulfhydryl reductants tris(2-carboxyethyl)phosphine and dithiothreitol for use in protein biochemistry. Anal Biochem 1999;273:73-80.
24. Hammarstrom P, Sekijima Y, White JT, Wiseman RL, Lim A, Costello CE, et al. D18G transthyretin is monomeric, aggregation prone, and not detectable in plasma and cerebrospinal fluid: a prescription for central nervous system amyloidosis? Biochemistry 2003;42:6656-63.
25. Connors LH, Lim A, Prokaeva T, Roskens VA, Costello CE. Tabulation of human transthyretin (TTR) variants, 2003. Amyloid 2003;10:160-84.
26. Lim A, Prokaeva T, McComb ME, Connors LH, Skinner M, Costello CE. Identification of S-sulfonation and S-thiolation of a novel transthyretin Phe3Cys variant from a patient diagnosed with familial transthyretin amyloidosis. Protein Sci 2003;12:1775-85.
27. Bergquist J, Andersen O, Westman A. Rapid method to characterize mutations in transthyretin in cerebrospinal fluid from familial amyloidotic polyneuropathy patients by use of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Clin Chem 2000;46:1293-300.
28. Theberge R, Connors L, Skinner M, Skare J, Costello CE. Characterization of transthyretin mutants from serum using immunoprecipitation, HPLC/electrospray ionization and matrix-assisted laser desorption/ionization mass spectrometry. Anal Chem 1999;71: 452-9.
29. Steiner I. The prevalence of isolated atrial amyloid. J Pathol 1987;153:395-8.
30. Hesse A, Altland K, Linke RP, Almeida MR, Saraiva MJ, Steinmetz A, et al. Cardiac amyloidosis: a review and report of a new transthyretin (prealbumin) variant. Br Heart J 1993;70:111-5.
31. Cornwell GG 3rd, Murdoch WL, Kyle RA, Westermark P, Pitkanen P. Frequency and distribution of senile cardiovascular amyloid. A clinicopathologic correlation. Am J Med 1983;75:618-23.